ASKLEPIOS BIOPHARMACEUTICAL

asklepios-biopharmaceutical-logo

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders and other rare diseases. It offers proprietary AAV technology, manufacturing capabilities, and a robust pipeline of in-house clinical programs for clients in the medical biopharmaceutical industry. Its pipeline includes clinical-stage programs in Pompe disease and congestive heart failure and a diverse preclinical portfolio of therapeutics targeting neuromuscular, C... NS, and other diseases, as well as out-licensed clinical indications for hemophilia and Duchenne muscular dystrophy. The company’s gene therapy platform includes Pro10, an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid, and promoter library. Asklepios BioPharmaceutical was founded in 2001 and is headquartered in Research Triangle Park, North Carolina.

#SimilarOrganizations #People #Financial #Event #Website #More

ASKLEPIOS BIOPHARMACEUTICAL

Social Links:

Industry:
Biopharma Biotechnology Health Care Manufacturing Medical Medical Device

Founded:
2001-01-01

Address:
Chapel Hill, North Carolina, United States

Country:
United States

Website Url:
http://www.askbio.com

Total Employee:
501+

Status:
Active

Contact:
+1 (919) 561-6210

Total Funding:
241.76 M USD

Technology used in webpage:
Person Schema Gravatar Profiles U.S. Server Location WP Engine Getty Images


Similar Organizations

avinger-logo

Avinger

Avinger is a medical device company engaged in developing catheter-based technologies and devices for treating vascular diseases.

bolt-threads-logo

Bolt Threads

Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future.

immunome-logo

Immunome

Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.

jenavalve-technology-logo

JenaValve Technology

JenaValve is a medical device company focused on the design and development of innovative transcatheter heart valve solutions

masimo-logo

Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products.

mediwound-logo

MediWound

MediWound is a biotechnology specialty company focused on developing, manufacturing and commercializing innovative wound care products.

ngm-biopharmaceuticals-logo

NGM Biopharmaceuticals

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

resmed-logo

ResMed

A global leader in digital health and connected medical devices, plus software solutions that support out-of-hospital care providers.

shine-medical-technologies-logo

SHINE Medical Technologies

SHINE Medical Technologies manufactures and supplies medical tracers and cancer treatment elements.

vaxart-logo

Vaxart

Vaxart is a biotechnology company that develops vaccine technology for the treatment of infectious diseases.


Current Advisors List

marianne-de-backer_image

Marianne De Backer Member Board of Directors ( A bayer company ) @ Asklepios BioPharmaceutical
Board_member
2020-11-01

Current Employees Featured

r-jude-samulski_image

R. Jude Samulski
R. Jude Samulski President, Chief Scientific Officer & Co-Founder @ Asklepios BioPharmaceutical
President, Chief Scientific Officer & Co-Founder
2003-01-01

david-c-venables_image

David C. Venables
David C. Venables President @ Asklepios BioPharmaceutical
President

martin-k-childers_image

Martin K. Childers
Martin K. Childers CMO @ Asklepios BioPharmaceutical
CMO

philip-dana_image

Philip Dana
Philip Dana Chief Human Resources Officer @ Asklepios BioPharmaceutical
Chief Human Resources Officer
2022-01-01

michael-l-kranda_image

Michael L. Kranda
Michael L. Kranda SVP CNS Practice Lead @ Asklepios BioPharmaceutical
SVP CNS Practice Lead
2010-07-01

not_available_image

Samuel Hopkins
Samuel Hopkins Sr. Vice President, Therapeutics @ Asklepios BioPharmaceutical
Sr. Vice President, Therapeutics
2018-03-01

mansuo-l-shannon_image

Mansuo L Shannon
Mansuo L Shannon Chief Scientific Officer @ Asklepios BioPharmaceutical
Chief Scientific Officer
2024-04-01

sheila-ann-mikhail_image

Sheila Ann Mikhail
Sheila Ann Mikhail Co-Founder @ Asklepios BioPharmaceutical
Co-Founder
2017-04-01

rebecca-boone_image

Rebecca Boone
Rebecca Boone Senior Vice President, Clinical Operations @ Asklepios BioPharmaceutical
Senior Vice President, Clinical Operations
2021-02-01

ken-macnamara_image

Ken Macnamara
Ken Macnamara SVP, UK Science and Site Lead @ Asklepios BioPharmaceutical
SVP, UK Science and Site Lead
2022-08-01

Founder


jude-samuski_image

Jude Samuski

r-jude-samulski_image

R. Jude Samulski

sheila-ann-mikhail_image

Sheila Ann Mikhail

Acquisitions List

Date Company Article Price
2020-04-22 Brainvectis Brainvectis acquired by Asklepios BioPharmaceutical N/A
2019-09-17 RoverMed BioSciences RoverMed BioSciences acquired by Asklepios BioPharmaceutical N/A
2019-08-13 Synpromics Ltd Synpromics Ltd acquired by Asklepios BioPharmaceutical N/A

Investors List

scottish-enterprise_image

Scottish Enterprise

Scottish Enterprise investment in Grant - Asklepios BioPharmaceutical

vida-ventures_image

Vida Ventures

Vida Ventures investment in Private Equity Round - Asklepios BioPharmaceutical

tpg-capital-asia_image

TPG Capital Asia

TPG Capital Asia investment in Private Equity Round - Asklepios BioPharmaceutical

muscular-dystrophy-association_image

Muscular Dystrophy Association

Muscular Dystrophy Association investment in Grant - Asklepios BioPharmaceutical

muscular-dystrophy-association_image

Muscular Dystrophy Association

Muscular Dystrophy Association investment in Grant - Asklepios BioPharmaceutical

Key Employee Changes

Date New article
2024-04-09 AskBio appoints new chief scientific officer

Official Site Inspections

http://www.askbio.com Semrush global rank: 2.55 M Semrush visits lastest month: 7.23 K

  • Host name: 172.99.75.43
  • IP address: 172.99.75.43
  • Location: San Antonio United States
  • Latitude: 29.4963
  • Longitude: -98.4004
  • Metro Code: 641
  • Timezone: America/Chicago
  • Postal: 78218

Loading ...

More informations about "Asklepios BioPharmaceutical"

Updated AskBio Leadership Structure Reflects Strategic Focus

Oct 13, 2023 “This move ensures that we have the leadership required to build on our more than 20 years of groundbreaking discovery experience and become a high-performing delivery …See details»

Ask Bio - a Gene Therapy Company in RTP, North …

AskBio is headquartered in Research Triangle Park, North Carolina, a thriving biotechnology hub with nearly 600 life science companies. Research and development facilities are located in Philadelphia, Pennsylvania; Upper …See details»

AskBio Announces 15 Presentations at American Society of Gene …

1 day ago Research Triangle Park, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Three oral and 12 poster presentations demonstrate breadth and progress of AskBio’s gene therapy research …See details»

AskBio Inc. - LinkedIn

AskBio Inc. | 40,013 followers on LinkedIn. AskBio Inc., a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to …See details»

AskBio Announces 15 Presentations at American Society of

17 hours ago Viralgen, founded in 2017 as a subsidiary of AskBio Inc. within the Bayer AG group, is a Contract Development and Manufacturing Organization (CDMO) specializing in the …See details»

AskBio - 2025 Company Profile, Funding & Competitors - Tracxn

Apr 25, 2025 AskBio is an acquired company based in Durham (United States), founded in 2001 by Sheila Mikhail and Jude Samulski. It operates as a Provider of gene and protein therapies …See details»

AskBio Company Profile | Management and Employees List

AskBio Profile and History. AskBio, is a fully integrated molecular medicine and technology company with operations around the globe. AskBio remains dedicated to the advancement of …See details»

Bayer Acquires Asklepios BioPharmaceutical to Broaden ... - TPG Inc.

Berlin, Germany and Research Triangle Park, N.C. – October 26, 2020 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio) today announced an agreement under which Bayer will …See details»

Sitting Down With… Sheila Mikhail, CEO and Co …

Jul 6, 2023 Sitting Down With… Sheila Mikhail, CEO and co-founder, AskBio; founder, Columbus Children’s Foundation. After featuring in The Medicine Maker Power List 2023, Mikhail shares her expertise as a lawyer, a leader, and a …See details»

Pioneers in Gene Therapy - Leadership Team - AskBio

The AskBio Team. The AskBio team is comprised of some of the most accomplished and experienced genetic researchers, clinicians and biopharmaceutical industry veterans. Our founders are pioneers in the field of …See details»

AskBio Receives FDA Regenerative Medicine Advanced Therapy …

Feb 19, 2025 Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Regenerative Medicine Advanced Therapy …See details»

Working at Asklepios BioPharmaceutical - Zippia

Mar 14, 2024 Organization Type. Private. Social Media. Asklepios BioPharmaceutical, Inc. (AskBio) is a privately held AAV gene therapy based company founded in 2001 to advance the …See details»

AskBio Announces Strategic Collaboration with ReCode ... - Bayer

Jan 9, 2023 AskBio’s gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global …See details»

AskBio Announces 15 Presentations at American Society of Gene …

1 day ago Research Triangle Park, N.C.– MAY 8, 2025 – AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, will deliver …See details»

Bayer Acquires AskBio to Broaden Innovation Base in Cell and …

Oct 20, 2015 About AskBio Founded in 2001, Asklepios BioPharmaceutical, Inc. (AskBio) is a privately held, clinical-stage gene therapy company dedicated to improving the lives of children …See details»

AskBio Announces 15 Presentations at American Society of Gene …

17 hours ago Viralgen, founded in 2017 as a subsidiary of AskBio Inc. within the Bayer AG group, is a Contract Development and Manufacturing Organization (CDMO) specializing in the …See details»

Bayer buys cell & gene therapy firm AskBio for $4 billion

Oct 26, 2020 Bayer is making clear its ambitions in cell and gene therapy with a $4 billion acquisition of US biotech Asklepios BioPharmaceutical, also known as AskBio. AskBio’s …See details»

AskBio Receives FDA Regenerative Medicine Advanced Therapy …

Feb 19, 2025 AskBio Inc. a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that investigational gene therapy AB-1005 for the …See details»

Our Focus Areas for Genetic Research | AskBio

AskBio scientists were among the first to introduce gene therapies for various forms of muscular dystrophy. As the first for-profit organization to receive a grant from the Muscular Dystrophy …See details»

Inside the $4B AskBio deal, the third largest buyout ever for an NC ...

Oct 27, 2020 Bayer will own AskBio’s gene therapy platform, including a broad intellectual property portfolio and a contract development and manufacturing organization based on …See details»

linkstock.net © 2022. All rights reserved